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Comparison of Rheolytic Thrombectomy Before Direct
Infarct Artery Stenting Versus Direct Stenting Alone in
Patients Undergoing Percutaneous Coronary
Intervention for Acute Myocardial Infarction
David Antoniucci, MD, Renato Valenti, MD, Angela Migliorini, MD, Guido Parodi, MD,
Gentian Memisha, MD, Giovanni Maria Santoro, MD, and Roberto Sciagra`, MD
This randomized trial compared rheolytic thrombec-
tomy before direct infarct artery stenting with direct
infarct artery stenting alone in 100 patients with a first
acute myocardial infarction (AMI). The primary end
point of the study was early ST-segment elevation res-
olution, and the secondary end points were corrected
Thrombolysis In Myocardial Infarction (TIMI) frame
count, infarct size, and 1-month clinical outcome. The
primary end point rates were 90% in the thrombectomy
group and 72% in the placebo group (p  0.022).
Randomization to thrombectomy was independently re-
lated to the primary end point (odds ratio 3.56, p 
0.032). The corrected Thrombolysis In Myocaridal In-
farctions (TIMI) frame count was lower in the thrombec-
tomy group (18.2  7.7 vs 22.5  11.0, p  0.032),
and infarct size was smaller in the thrombectomy group
(13.0  11.6% vs 21.2  18.0%, p  0.010). At 1
month, there were no major adverse cardiac events.
Rheolytic thrombectomy before routine direct infarct-
related artery (IRA) stenting is highly feasible and pro-
vides more effective myocardial reperfusion in patients
undergoing percutaneous coronary intervention for
AMI. 2004 by Excerpta Medica, Inc.
(Am J Cardiol 2004;93:1033–1035)
Macro- and microembolization during percutane-ous coronary intervention (PCI) is frequent and
may result in the obstruction of the microvessel cor-
onary network.1 In the setting of acute myocardial
infarction (AMI), PCI-related embolization results in
a decreased efficacy of mechanical reperfusion and
myocardial salvage. Direct stenting without predila-
tion may decrease embolization and the incidence of
the no-reflow phenomenon.2,3 More specific ap-
proaches to the problem of microvessel embolization
during PCI include thrombectomy by different tech-
niques and the use of anti-embolic protection devices.
One randomized trial has reported rheolytic thrombec-
tomy to be effective in decreasing embolization in
patients who underwent PCI on venous grafts or na-
tive coronary vessel with massive thrombosis4; how-
ever, few data exist on the effectiveness of rheolytic
thrombectomy in the setting of AMI.5,6 This random-
ized trial assessed the efficacy of rheolytic thrombec-
tomy before direct infarct artery stent implantation in
patients who underwent PCI for AMI.
• • •
Criteria for enrollment included chest pain persisting
30 minutes associated with an ST-segment elevation of
0.1 mV in 2 contiguous electrocardiographic leads.
The exclusion criteria included (1) previous myocardial
infarction, (2) administration of fibrinolytic therapy, (3)
bundle branch block or ventricular pacing on the baseline
electrocardiogram preventing analysis of the ST-seg-
ment changes, (4) infarct-related artery (IRA) diameter
2.5 mm on visual angiographic assessment, and (5)
inability to obtain informed consent. Patients with car-
diogenic shock due to predominant ventricular failure
were included, as were patients with high-risk coronary
anatomy. After coronary angiography, eligible patients
were randomly assigned to direct IRA stenting alone or
thrombectomy before stenting. Computer-generated se-
quences and assignments using a closed envelope system
were used to perform randomization. Thrombectomy
was accomplished with the second-generation rheolytic
thrombectomy 4Fr catheter (AngioJet, Possis Medical,
Minneapolis, Minnesota). Two types of stents were used:
a tubular closed-cell carbon-coated stent (Techno, Sorin,
Saluggia, Italy) and a tubular open-cell stent (Zeta,
Guidant, Santa Clara, California). All patients received
abciximab (ReoPro, Centocor, Malvern, Pennsylvania),
if not contraindicated, immediately before the procedure
as a bolus of 0.25 mg/kg of body weight followed by a
12-hour infusion at a rate of 0.125 g/kg/min. Heparin
was given as an initial bolus of 70 U/kg, and additional
boluses were administered during the procedure to
achieve an activated clotting time of 200 to 300 seconds.
Patients were routinely treated with aspirin (325 mg/day
indefinitely) and ticlopidine (500 mg/day for 1 month) or
clopidogrel (75 mg/day for 1 month).
The primary end point of the study was the effec-
tiveness of myocardial reperfusion as assessed by
ST-segment elevation resolution analysis. The sec-
ondary end points were (1) corrected Thrombolysis In
Myocardial Infarction (TIMI) frame count at the end
of the procedure, (2) infarct size as assessed by tech-
netium-99m sestamibi scintigraphy at 1 month, and
(3) 1-month clinical outcome.
A 12-lead electrocardiogram was recorded contin-
uously 30 minutes after infarct artery recanalization.
The ST-segment changes were evaluated in the single
lead, with the most prominent ST-segment elevation
From the Division of Cardiology and the Nuclear Medicine Institute,
Careggi Hospital, Florence, Italy. Dr. Antoniucci’s address is: Division
of Cardiology, Careggi Hospital, Viale Morgagni 85, I-50134, Flo-
rence, Italy. E-mail: carddept@tin.it. Manuscript received September
30, 2003; revised manuscript received and accepted January 3,
2004.
1033©2004 by Excerpta Medica, Inc. All rights reserved. 0002-9149/04/$–see front matter
The American Journal of Cardiology Vol. 93 April 15, 2004 doi:10.1016/j.amjcard.2004.01.011
before mechanical intervention. The ST-segment ele-
vation was measured to the nearest 0.5 mm at 60 ms
after the J point with the aid of hand-held calipers. A
previous study7 defined early ST-segment elevation
resolution as a 50% decrease in ST-segment eleva-
tion at 30 minutes after IRA recanalization.
Quantitative coronary angiography included the as-
sessment of TIMI grade flow, TIMI frame count,
reference infarct artery diameter, and minimum lumen
diameter. These quantitative angiographic parameters
were assessed as previously described.8–10
The 1-month technetium-99m sestamibi scintigra-
phy and determination of infarct size at 1 month were
performed as previously described.11
Investigators unaware of patients’ treatment as-
signments and clinical outcomes performed indepen-
dent analyses of the electrocardiograms, scintigrams,
and angiograms.
The sample size was calculated on the following
assumption: early ST-segment resolution would occur in
68% of patients randomized to direct stenting alone and
in 90% of patients randomized to thrombectomy before
stenting. To detect a difference with 80% power and a
type I error () of 0.05, 50 patients per
group were required. Discrete data are
summarized as frequencies, and con-
tinuous data are summarized as mean
 SD. Chi-square test analysis was
used for comparison of categorical
variables. Student’s t test was used to
test differences among continuous
variables. Forward stepwise multivari-
ate logistic regression analysis was
performed to identify independent cor-
relates of the primary end point. All
analyses were conducted according to
the intention-to-treat principle. A p
value 0.05 was considered statisti-
cally significant. Analyses were per-
formed with SPSS 8.0 (SPSS Inc.,
Chicago, Illinois).
Between November 2002 and
June 2003, 137 patients with AMI
underwent PCI, and 100 were ran-
domized to direct infarct artery stent-
ing alone or thrombectomy before
direct infarct artery stenting. The rea-
sons for excluding 37 patients from
randomization were previous myo-
cardial infarction (n  18), infarct
artery diameter 2.5 mm (n  8),
bundle branch block or ventricular
pacing (n  3), and inability to ob-
tain informed consent (n  8).
Table 1 lists the baseline patient
characteristics and the procedural data.
Patients treated with direct stenting
alone had a greater incidences of a
history of angina, anterior AMI, and
cardiogenic shock, but these differ-
ences did not reach statistical signifi-
cance. There were no primary PCI fail-
ures. Overall, 98% of patients had direct IRA stenting.
The thrombectomy device directly crossed the occlusion
in 48 patients (96%), but the device crossed the target
lesion only after predilation with a 2.0-mm angioplasty
balloon in 2 patients. Thrombectomy increased TIMI
infarct artery flow from 0.60  1.09 to 2.82  0.56 (p
0.001). Four patients treated with the stent alone were
then treated with thrombectomy because of residual an-
giographic evidence of massive thrombosis after direct
stenting. Nearly all patients in the 2 groups were treated
with abciximab.
The end point rates and outcomes are listed in Table
2. The early ST-segment resolution rate was higher in the
thrombectomy group than in the stenting-only group, and
TIMI frame count was lower in the thrombectomy
group. The 1-month technetium-99m sestamibi scinti-
grams showed smaller infarcts in the thrombectomy
group than in the stenting-only group. At 1 month, there
were no major adverse cardiac events. In patients with-
out anterior AMI, early ST-segment resolution was more
frequent (94% vs 70%; p  0.015) and the infarct size
was smaller (13.6 10.4 vs 19.6 14.1; p 0.063) in
the thrombectomy group than in the stenting-only group.
TABLE 1 Baseline Characteristics and Procedural Data
Variable
Thrombectomy
(n  50)
Placebo
(n  50) p Value
Age (yrs) (mean  SD) 63  13 66  12 0.251
Men 41 (82%) 39 (78%) 0.617
Current smoker 19 (38%) 14 (28%) 0.288
Hypertension 18 (36%) 19 (38%) 0.836
Cholesterolemia 200 mg/dl 23 (46%) 24 (48%) 0.841
Diabetes mellitus 9 (18%) 8 (16%) 0.790
Angina pectoris 10 (20%) 4 (8%) 0.084
Anterior wall acute myocardial infarction 17 (34%) 23 (46%) 0.221
Cardiogenic shock 3 (6%) 6 (12%) 0.295
Infarct coronary artery 0.470
Left anterior descending 17 (34%) 23 (46%)
Right 26 (52%) 21 (42%)
Circumflex 7 (14%) 6 (12%)
Multivessel coronary disease 15 (30%) 20 (40%) 0.295
Preprocedural TIMI grade flow 0–1 38 (76%) 40 (80%) 0.629
Time-to-treatment (h) (mean  SD) 3.9  2.0 4.4  2.8 0.295
Infarct artery stenting 49 (98%) 49 (98%) 1.000
Direct stenting 47 (94%) 41 (82%) 0.065
Multiple stents 12 (24%) 13 (26%) 0.817
Stent length (mm) 20.7  9.2 21.1  20.1 0.848
Rheolytic thrombectomy 48 (96%) 4 (8%) 0.001
Abciximab administration 49 (98%) 49 (98%) 1.000
Intra-aortic balloon counterpulsation 3 (6%) 5 (10%) 0.461
TABLE 2 End Points
Variable
Thrombectomy
(n  50)
Placebo
(n  50)
p
Value
Early ST-segment elevation resolution 45 (90%) 36 (72%) 0.022
Corrected TIMI frame count
(mean  SD)
18.2  7.7 22.5  11.0 0.032
Technetium-99m sestamibi infarct size (%)
(mean  SD)
13.0  11.6 21.2  18.0 0.010
Death 0 0
Reinfarction 0 0
Target vessel revascularization 0 0
Major bleeding requiring blood transfusion 0 1 (2%) 0.315
Disabling stroke 1 (2%) 0 0.315
*Mean  SD.
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By multivariate analysis, the only variables related to
the primary end point were randomization to thrombec-
tomy (odds ratio 3.56, 95% confidence interval 1.11 to
11.42, p 0.032), and diabetes mellitus (odds ratio 0.24,
95% confidence interval 0.07 to 0.86, p  0.029).
• • •
This study assessed the efficacy of rheolytic throm-
bectomy as adjunctive management before routine direct
stenting and avoided the confounding effects of proce-
dural variables other than direct stenting, such as con-
ventional balloon angioplasty, conventional stenting be-
fore or after dilation, and use or nonuse of abciximab.
This feature allowed a correct assessment of the potential
of rheolytic thrombectomy for prevention of atheroem-
bolism during PCI. The principal finding from the
present trial was that rheolytic thrombectomy before
routine direct infarct artery stenting is highly feasible and
provides more effective myocardial reperfusion as
shown by the more frequent early ST-segment resolu-
tion, the lower TIMI frame count values, and smaller
infarcts in patients randomized to thrombectomy versus
patients randomized to stenting only. After adjustment
for differences in clinical, angiographic, and procedural
characteristics by multivariate analysis, rheolytic throm-
bectomy remained independently related to the primary
end point. Thus, it is unlikely that the nonsignificant
baseline characteristic imbalance between groups af-
fected the primary end point.
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Effect of Hypnotic Sedation During Percutaneous
Transluminal Coronary Angioplasty on Myocardial
Ischemia and Cardiac Sympathetic Drive
Roberto Baglini, MD, PhD, Marco Sesana, MD, Cinzia Capuano, MD,
Tomaso Gnecchi-Ruscone, MD, Limbruno Ugo, MD, PhD, and Gian Battista Danzi, MD
Forty-six patients were randomized to receive drug
(group 1) or hypnotic sedation (group 2) during percu-
taneous transluminal coronary angioplasty of the left
anterior descending coronary artery. Intracoronary and
standard electrocardiograms were continuously regis-
tered, and heart rate spectral variability was studied.
Normalized units of low- and high-frequency compo-
nents and the ratio of low to high frequency were
measured during balloon inflations. The ST segment
shifted at the first balloon inflation from 0.02 0.01 to
0.09 0.6 mm in group 1 and from 0.02 0.08 to 0.1
 0.6 in group 2 mm (p <0.05). In group 1, the
low-frequency band and the ratio of low to high fre-
quency increased significantly during the first balloon
inflation (from 59  10 to 75  10 normalized units
and from 2.4  1.4 to 7.3  4.7, respectively; p
<0.001). The increase of the ratio of low to high fre-
quency was significantly related to ST shift (r  0.706;
p <0.01). In contrast, no significant variation of spectral
parameters was found in group 2. The increase in car-
diac sympathetic activity associated with balloon infla-
tion and myocardial ischemia during percutaneous
transluminal coronary angioplasty of the left anterior
descending coronary artery was selectively eliminated
by hypnosis but not by drug sedation. 2004 by
Excerpta Medica, Inc.
(Am J Cardiol 2004;93:1035–1038)
Percutaneous transluminal coronary angioplasty(PTCA) is used widely in patients with coronary
artery disease. During balloon inflation, brief periods
of myocardial ischemia are followed by immediate
reperfusion, but few and inconclusive data are avail-
able about the influence of these short periods of
myocardial ischemia and reperfusion on the cardiac
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